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A B S T R A C T
Catheter ablation of atrial fibrillation (AF) has become a viable therapeutic alterna-
tive in symptomatic patients resistant to antiarrhythmic drugs. Since the first report 
of catheter ablation a decade ago, several techniques have evolved. These techniques 
reflect principal mechanisms of AF. Besides segmental electrical isolation, circumfer-
ential ablation around the pulmonary venous ostia with a support of the 3D electro-
anatomical mapping system appears to be the most frequently used techniques. Some 
authors use various combinations of these techniques including guidance with intra-
cardiac echocardiography (ICE). Most recently, ablation within areas of fractionated 
electrograms during AF has been proposed. The aim of this review is to summarize 
briefly current techniques, their efficacy and safety.
I N T R O D U C T I O N
Catheter ablation of atrial fibrillation (AF) has become a viable therapeutic alter-
native in symptomatic patients resistant to antiarrhythmic drugs. Since the first report 
of catheter ablation a decade ago, several techniques have evolved. These techniques 
reflect principal mechanisms of AF. The aim of this review is to summarize briefly 
current techniques, their efficacy and safety.
F R O m  m A Z E  S U R g E R y  T O  S E g m E N T A l  p U l m O N A R y  v E N O U S 
I S O l A T I O N
The multiple wavelet hypothesis suggested by Moe and Abildskov in the late fif-
ties was the most accepted mechanism of AF until recently.1 It stated that AF occurs 
due to random movement of multiple wavelets throughout the atria. Experimental 
support for this mechanism was provided by Allessie et al who discovered that four to 
six wavelets were important for sustenance of AF.2 Most importantly, this hypothesis 
resulted in development of the first curative approach to AF – MAZE surgery.3 This 
ingenious technique has been designed to reduce critical mass of the tissue, prevent 
movement of multiple circuits within the atria and around the caval veins, and to 
isolate pulmonary veins. The reported success rate reached above 95% with periop-
erative mortality around 2%. However, its complexity and potential for complications 
prevented wider use of the MAZE procedure.4 Not surprisingly, electrophysiologists 
soon tried to reproduce this scheme of lines using various catheter techniques.5,6 
Early in this stage of development, it has been realized that linear ablation within 
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the right atrium is much less successful in abolition of AF as 
compared with lesions in the left atrium.7 Reproduction of 
MAZE-like linear lesions within the left atrium was found 
technically difficult and again, associated with a high risk of 
complications. During these early attempts, Haissaguerre et 
al8 described the first three cases of focal mechanism of AF. 
Foci of spontaneous electrical activity that triggered AF were 
described predominantly within pulmonary veins and became 
the target for ablative attempts.9 Subsequent anatomical 
studies confirmed previous observations about the presence 
of atrial muscular sleeves around the ostia of the pulmonary 
veins10,11 and one of the recent publications revealed the pres-
ence of node-like cells in these muscular extensions.12 All 
these observations revived the hypothesis of a rapidly firing 
focus that was described in 1925 by Sir Thomas Lewis.13 Fur-
ther experimental support for this mechanism was provided 
by Scherf et al,14 who used local application of aconitine to 
initiate AF and demonstrated that subsequent obliteration 
of the site of application leads to termination of AF. Other 
studies have shown that episodic bursts of electrical activity 
with a distal-to-proximal activation of the pulmonary vein,15 
suggesting their role in AF maintenance. After a period of 
focal ablations within the pulmonary veins, Haissaguerre et 
al16 came with a concept of selective electrical isolation of ar-
rhythmogenic or all pulmonary veins. The concept reflected 
variable arrangement of muscular fibers around the ostia with 
some preferential routes of conduction from the vein and vice 
versa. Using a purpose-constructed circular mapping catheter 
(Lasso, Biosense-Webster, Diamond Bar, CA, USA), this 
group was able to map sites of the conduction and destroy 
them selectively instead of burning the whole circumference 
of the pulmonary vein ostia. After initial excitement, several 
limitations of this approach have been revealed. First, it ap-
pears to work predominantly in subjects with clear evidence 
of focus-triggered AF (i.e. subjects with multiple runs of 
self-terminating AF initiated by frequent premature ectopic 
beats) and less in patients with persistent or permanent AF. 
The success rate of this procedure ranges between 60-80%, 
the best results occurring in patients with paroxysmal AF and 
without structural heart disease.17 Second, there is a risk of 
pulmonary vein stenosis (1-3%) that can be very symptomatic 
and optimal treatment of which is still unknown. Third, the 
long-term success is impaired by very frequent recovery of 
conduction, and many subjects require repeated procedures.18 
This may reflect minimalistic energy delivery in the proximal 
segments of the pulmonary veins in an attempt to eliminate 
risk of pulmonary venous stenosis.
C I R C U m F E R E N T I A l  A B l A T I O N  A R O U N D 
p U l m O N A R y  v E N O U S  O S T I A
Parallel to significant research work of the Bordeaux 
group, Pappone et al developed their own strategy to treat 
AF.19,20 Using a 3D electroanatomical mapping system 
(CARTO, Biosense Webster, Haifa, Israel), this group started 
to use circumferential deployment of radiofrequency lesions 
around the pulmonary venous ostia. The endpoint for ablation 
was signal amplitude abatement ≤0.1 mV and local activation 
time difference between points on both sides of a line >30 
ms (as confirmed by a remap around ostia). Although a com-
plete electrical isolation of the pulmonary veins is relatively 
rare with this technique, a substantial modification of the 
substrate and/or partial denervation of the heart seem to be 
its main results. It does not refute the concept of focal origin 
of AF. However, it may also prevent the formation of stable 
rotors out of the pulmonary veins which could maintain AF. 
These vortex-like reentry circuits have been described in the 
posterior left atrium and pulmonary venous ostia by Jalife et 
al using a high-resolution optical mapping.21 Rapid electri-
cal impulses originating from these rotors then propagate 
throughout the atria and sustain fibrillatory conduction. The 
efficacy of Pappone s΄ method has been confirmed by its au-
thors as well as by others.22 The success rate ranges between 
75 to 90%. Non-randomized comparison of medical treatment 
with catheter ablation documented better prognosis of subjects 
treated interventionally.23 Comparison of circumferential 
ablation around the pulmonary venous ostia with segmen-
tal isolation within proximal segments of the pulmonary 
veins showed higher long-term success rate for the former 
technique.24 At 6 months, 88% of patients who underwent 
circumferential ablation and 67% of patients who underwent 
segmental isolation were free of symptomatic PAF when not 
taking antiarrhythmic drug therapy. In the same time, the risk 
of pulmonary venous stenosis is lower when radiofrequency 
energy is applied around the ostia. However, a new and seri-
ous complication of this approach has recently been described 
– atrio-esophageal fistula.25
C O m B I N E D  T E C h N I q U E S
Limited success rate of either of the above techniques 
has led to development of combined techniques. Mansour et 
al 26 described a novel method of circumferential extraostial 
isolation of the pulmonary veins, combining electroanatomical 
mapping and the use of Lasso catheter. Isolation of the right 
and left pulmonary veins was achieved by a single encirclement 
of ipsilateral veins. This approach led to abolition of AF in 75% 
of patients as compared with 60 % in a group with segmental 
isolation within the pulmonary venous ostia. There was one 
thromboembolic complication in each group. Natale et co-
workers 27 described another combined technique that uses 
intracardiac echocardiography (ICE) to visualize pulmonary 
venous ostia and the Lasso mapping catheter for assessment 
of local signals and assessment of complete electrical isolation 
of the veins. The position of the Lasso catheter is controlled by 
ICE and continuously adjusted to eventually cover the whole 
circumference of the veno-atrial junction. This allows deploy-
ment of the lesions at the level of veno-atrial junction and in 
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the same time, assessment of electrical isolation of the relevant 
pulmonary vein. Initial experience with this novel approach 
resulted in a discovery of the phenomenon of “microbub-
bles” during radiofrequency energy delivery. Appearance of 
microbubbles reflects tissue overheating and precedes sudden 
increase of impedance and/or “pop” phenomenon. Monitoring 
of gradually increasing radiofreqeuency energy delivery seems 
to prevent complications as well as allows administration of 
a relatively high energy to the tissue. All the above potential 
advantages appear to contribute to very high efficacy and 
safety of this technique, both in patients without and with 
structural heart disease and in patients with paroxysmal as 
well as persistent AF. The reported success rate reaches above 
90% and 70%, respectively.27,28
A B l A T I O N  O F  A N  E l E C T R O p h y S I O l O g I C A l 
S U B S T R A T E
Theory of mother rotors with subsequent fibrillatory 
conduction and previous experimental data 21 led to attempts 
to modify electrophysiological substrate for these reentry 
circuits. One of them was minimally invasive surgical ap-
proach in subjects without significant structural heart dis-
ease. Simple scheme of linear lesions created by a hand-held 
radiofrequency probe was designed to interconnect ostia of 
the pulmonary veins connect them with the mitral annulus 
in order to destroy periostial anchoring reentrant circuits.29 
Despite the fact that the pulmonary veins were not isolated 
with this technique, both mid- and long-term success (between 
93-97%) were higher than reported for segmental isolation of 
the pulmonary veins. Further sophistication of the technique 
that is primarily focused on abolition of rotors was introduced 
by Nademanee et al30 who used electroanatomical mapping 
of both atria to annotate areas with complex and fragmented 
local electrograms in an anatomical map. These areas were 
localized predominantly on the posterior left atrial wall and/or 
in the septal region. Catheter ablation within these areas led 
to interruption of AF in 115 of 121 patients and prevented the 
recurrence of arrhythmia at one-year follow-up in 92 of 121 
(76%) after the first procedure and in 110 of 121 (91%) after 
the second procedure. The mechanism by which the ablation 
within areas of fragmented potentials prevents recurrence of 
AF is not clear. Rather extensive ablation may eliminate some 
triggers in the periostial area, eliminate or modify abnormal 
atrial substrate needed for maintenance of AF and/or modu-
late cardiac parasympathetic activity.
T h E  p R A g U E  C U R R E N T  A p p R O A C h
At present, most of the centers use circumferential abla-
tion supported by electroanatomical mapping. Following 
previous experience with segmental isolation and then with 
circumferential ablation, we started to use ICE in associa-
tion with electroanatomical mapping system and the Lasso 
catheter. One of the reasons for this move was observed 
variability in pulmonary venous ostial arrangement that does 
not allow accurate location of the pulmonary venous ostia 
by electroanatomical mapping system.31 The other reason 
was to improve efficacy and safety similar to that reported 
by Manssour et al.26 So far, we performed 23 procedures in 
patients with and without structural heart disease, and 12 of 
them has minimum follow up of 2 months. Eight subjects are 
without AF, one reported symptomatic improvement and the 
remaining three continue to have symptoms. Although it is 
early to analyze efficacy of the above approach, we believe 
that ICE may provide significant help in catheter ablation of 
AF regardless the method used. First, it can be used to assist 
transseptal puncture, especially in difficult anatomy of the 
septum (e.g. lipomatous hypertrophy etc) (Figure 1). Second, 
ICE is able to identify intracardiac thrombi that develop during 
the procedure and thus, has a potential to minimize a risk of 
thromboembolism.32 Third, ICE allows visualization of all pul-
monary veins, their arrangement and size (Figure 2). It enables 
precise placement of the lasso catheter at the level of venoatrial 
junction (Figure 3) and of the ablation catheter proximal to it. 
Fourth, it may help to create adequate radiofrequency lesions 
by monitoring of power delivery and creation of microbubbles 
as a sign of tissue overheating (Figure 4). Fifth, ICE enables 
assessment of pulmonary venous blood flow before and after 
ablation and thus, estimation of venous stenosis.
C O N C l U S I O N S
The last decade has witnessed significant development 
of catheter ablation strategies to cure AF. Besides segmen-
tal electrical isolation, circumferential ablation around the 
pulmonary venous ostia with a support of the 3D electroana-
tomical mapping system appears to be the most frequently 
FIgURE 1. Intracardiac echocardiogram of both atria obtained 
immediately before transseptal puncture. Note tenting of the 
interatrial septum by transseptal needle (arrow) from the right 
atrium towards the left atrium (LA).
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FIgURE 2. An example of intracardiac echocardiogram of the 
left atrium (LA) and left-sided pulmonary veins (LIPV – left in-
ferior and LSPV – left superior pulmonary vein, respectively) 
with a common vestibule. Color Doppler documents flow to-
wards the LA.
FIgURE 3. Intracardiac echocardiogram of the left atrium (LA) 
showing the Lasso catheter held in the proximal part of the vesti-
bule. It is apparent that the Lasso is smaller than the diameter of 
the vestibule of left-sided veins (LIPV – left inferior and LSPV 
– left superior pulmonary vein, respectively).
FIgURE 4. Intracardial echocardiography of the left atrium 
(LA) during radiofrequency (RF) delivery through the tip of the 
ablation catheter (Abl). Large arrow depicts part of the Lasso 
catheter, small arrows show scattered microbubbles.
used techniques. Some authors use various combinations of 
these techniques including guidance with ICE. Most recently, 
electroanatomical mapping system was used to guide ablation 
within areas of fractionated electrograms during AF without 
any attempt for circumferential ablation of the pulmonary 
veins. Further progress can be achieved only through pre-
cise assessment of relative efficacy, safety and ease of these 
techniques.
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